Marilia Bernadette Voigt

Marilia Bernadette Voigt

Auto-generated profile, based on publicly available information

Marilia Bernadette Voigt

Department of Diagnostic and Interventional Radiology, University Hospital Bonn, Bonn, Germany

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2025 in Circulation: Cardiovascular Imaging
Verified
Journal Article
Closed access
TVThomas M. Vollbrecht
Thomas M. Vollbrecht
CHChristopher Hart
Christopher Hart
CKChristoph Katemann
Christoph Katemann
AIAlexander Isaak
Alexander Isaak
MVMarilia B. Voigt
Marilia B. Voigt
JLJulian A. Luetkens
Julian A. Luetkens
BACKGROUND: Fetal cardiovascular magnetic resonance is an emerging tool for prenatal congenital heart disease assessment, but long acquisition times and fetal movements limit its clinical use. This study evaluates the clinical utility of deep learning super-resolution reconstructions for rapidly acquired, low-resolution fetal cardiovascular magnetic resonance. METHODS: This prospective study included participants with fetal congenital heart disease undergoing fetal cardiovascular magnetic resonance in the third trimester of pregnancy, with axial cine images acquired at normal resolution and low resolution. Low-resolution cine data was subsequently reconstructed using a deep learning super-resolution framework (cine DL ). Acquisition times, apparent signal-to-noise ratio, contrast-to-noise ratio, and edge rise distance were assessed. Volumetry and functional analysis were performed. Qualitative image scores were rated on a 5-point Likert scale. Cardiovascular structures and pathological findings visible in cine DL images only were assessed. Statistical analysis included the Student paired t test and the Wilcoxon test. RESULTS: A total of 42 participants were included (median gestational age, 35.9 weeks [interquartile range (IQR), 35.1–36.4]). Cine DL acquisition was faster than cine images acquired at normal resolution (134±9.6 s versus 252±8.8 s; P <0.001). Quantitative image quality metrics and image quality scores for cine DL were higher or comparable with those of cine images acquired at normal-resolution (eg, fetal motion, 4.0 [IQR, 4.0–5.0] versus 4.0 [IQR, 3.0–4.0]; P <0.001). Nonpatient-related artifacts (eg, backfolding) were more pronounced in cine DL compared with cine images acquired at normal-resolution images (4.0 [IQR, 4.0–5.0] versus 5.0 [IQR, 3.0–4.0]; P <0.001). Volumetry and functional results were comparable. Cine DL revealed additional structures in 10 of 42 fetuses (24%) and additional pathologies in 5 of 42 fetuses (12%), including partial anomalous pulmonary venous connection. CONCLUSIONS: Deep learning super-resolution reconstructions of low-resolution acquisitions shorten acquisition times and achieve diagnostic quality comparable with standard images, while being less sensitive to fetal bulk movements, leading to additional diagnostic findings. Therefore, deep learning super-resolution may improve the clinical utility of fetal cardiovascular magnetic resonance for accurate prenatal assessment of congenital heart disease.

3 October 2023 in Current Cardiovascular Imaging Reports
Verified
Journal Article
Open access
PDF file
MVMarilia B. Voigt
Marilia B. Voigt
DKDmitrij Kravchenko
Dmitrij Kravchenko
AIAlexander Isaak
Alexander Isaak
AHAnnkristin Heine
Annkristin Heine
THTobias A. W. Holderried
Tobias A. W. Holderried
JLJulian A. Luetkens
Julian A. Luetkens
Purpose of Review: To review the current and future role of cardiovascular magnetic resonance (CMR) assessment of immunotherapy cardiotoxicity. Recent Findings: In patients who suffer from immune checkpoint inhibitor (ICI) myocarditis, pathologic CMR findings, including myocardial edema, reduced left ventricular ejection fraction (LVEF), late gadolinium enhancement (i.e., fibrosis and/or necrosis), and myocardial strain, are mostly subtle, but fulminant courses have been described. Individual cases of cardiotoxicity in chimeric antigen receptor (CAR) T cell therapy have also already been documented, but there are currently no studies addressing the role of CMR in CAR T cell therapy. There are also classes of immunotherapies for which no cases of cardiotoxicity are known yet, such as cytokines or adjuvants. Summary: Together with patient symptoms, laboratory markers, electrocardiogram, and echocardiography, CMR is of high value in the diagnostic workup of immunotherapy-associated myocarditis in hemodynamically stable patients, according to recent guidelines. Additionally, quantitative strain analysis and T1 relaxation times with CMR can aid in assessing disease severity, prognosis, and patient outcomes with ICI-associated myocarditis. Future CMR studies on cardiotoxicity in CAR T cell therapy are needed.

19 March 2025 in CVIR Endovascular
Verified
Journal Article
Open access
PDF file
MVMarilia B Voigt
Marilia B Voigt
PKPatrick A Kupczyk
Patrick A Kupczyk
AKAlexander Kania
Alexander Kania
CMCarsten Meyer
Carsten Meyer
JWJulia Wagenpfeil
Julia Wagenpfeil
DKDaniel Kuetting
Daniel Kuetting
Purpose: To identify the frequency and association of visceral arterial (VA) stenosis in peripancreatic aneurysms (PPAs) and to develop a uniform, more detailed treatment strategy for PPAs in case of accompanying VA stenosis, as current guidelines do not adequately address this constellation. Materials and methods: Patients with PPAs diagnosed at a tertiary care hospital were retrospectively analyzed. In case of multiple PPAs, the aneurysm with the highest aneurysm-to-vessel ratio (AVR) within the celiac-mesenteric collateral circulation was classified as the primary aneurysm and categorized as "critical" or "non-critical" based on the risk of organ ischemia. Celiac artery and superior mesenteric artery stenoses were graded as low (< 50%), high (> 50%), or total occlusion. Treatment strategies were based on VA stenosis severity, aneurysm classification, and morphology. Treatment strategies included endovascular, surgical and watch-and-wait management. Results: Thirty-one patients with PPAs were included with a total of 53 aneurysms; mean aneurysm size: 12.5 ± 7.9 mm (range 5–38 mm), AVR: 3.5 ± 2.1 (range 1–11.3). The superior and inferior pancreaticoduodenal arteries as well as the pancreaticoduodenal arcade were affected in most cases (67.9%). AVR was significantly higher in cases of aneurysm rupture (6.2 ± 2.8; p = 0.031). Celiac artery stenosis was present in 87.1%. Aneurysm size and occurrence of active bleeding did not correlate (p = 0.925). 11 patients presented with critical aneurysms, with 10 patients requiring individually tailored treatment. Non-critical aneurysms were treated with coil embolization in most cases. Conclusion: CA stenosis, aneurysm position, and AVR significantly influence treatment decisions. Individualized approaches based on anatomical and hemodynamic factors are needed in PPA treatment.

27 June 2026 in CVIR Endovascular
Verified
Journal Article
Open access
MVMarilia Bernadette Voigt
Marilia Bernadette Voigt
ABAlexander Böhner
Alexander Böhner
MBMohammed Bahaaeldin
Mohammed Bahaaeldin
JWJulia Wagenpfeil
Julia Wagenpfeil
TDTatjana Dell
Tatjana Dell
DKDaniel Kuetting
Daniel Kuetting
Purpose: To evaluate the occurrence of periaortic inflammation, including abscess formation, as a complication following endoleak repair after endovascular aortic repair. Materials and methods: This retrospective single-center study analyzed 88 EVAR revisions for endoleak treatment performed in 59 patients between 2015 and 2025. Patients underwent one to three revision procedures. Endoleaks were classified by type, and treatment was performed via transarterial access or direct sac puncture with a posterior/translumbar access route. Embolization materials for type II endoleaks included n-butyl-2-cyanoacrylate, ethylene vinyl alcohol, and coils, while stent-graft extensions and transmural fixation were used for type I and III endoleaks. Results: Of the 59 patients, 38 (64.4%) underwent one revision, 13 (22.0%) two revisions, and 8 (13.6%) three revisions. Treated endoleaks included type I (19.3%), type II (77.3%), type III (2.3%), and combined type II/III (1.1%). A total of 73 procedures (83.0%) were performed via transarterial access and 15 (17.0%) via direct sac puncture. Follow-up CT identified 6 cases of periaortic inflammation after type II endoleak repair, presenting with soft tissue mantle, fat stranding, or abscess formation. Symptom onset ranged from 33 to 108 days after the most recent intervention. No significant association was found between periaortic inflammation and access route or embolic material. Conclusion: Periaortic inflammation and abscess formation are possible severe complications after endoleak repair following endovascular aortic repair. To date, these inflammatory changes have not been described systematically in the literature and warrant further investigation.